Lawsuits have been mounting against drugmaker Pfizer alleging the company failed to warn the public that its top selling cholesterol-lowering statin Lipitor could cause type 2 diabetes.
Lipitor is prescribed to reduce the risk of heart attacks, strokes and cardiovascular death in patients with elevated cholesterol levels. It is one of the best selling drugs in the world.
In 2012, the Food and Drug Administration (FDA) issued a warning that patients treated with Lipitor could experience elevated blood sugar levels, which puts them at risk of developing type 2 diabetes. Postmenopausal women are at the greatest risk for developing the chronic disease.
Type 2 diabetes is a serious condition that requires patients to follow a strict diet and in some cases take medication to regulate blood sugar levels. Uncontrolled diabetes can lead to complications such as heart disease, kidney disease, dementia, blindness and amputations.
The multi-district litigations against Lipitor are growing rapidly. Plaintiffs claim that Pfizer knew the risks associated with Lipitor but withheld the information from doctors and patients in order to reap bigger profits. Lipitor has generated more than $125 billion in sales from its approval in 1996 to 2012, and at the time was the world’s best-selling drug. When Pfizer’s patent on Lipitor expired in November 2011, generic versions became available and Lipitor sales began to slowly decline.
More commonly known Lipitor side effects include a potentially life threatening muscle injury and liver damage.
Patients who have used Lipitor and developed diabetes should first consult with their doctors and then seek assistance from an attorney as they may have a case against the manufacturer.
Source: My Sun Coast